BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 17436653)

  • 1. [Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery].
    Varela Crespo CA; Sanabria Carretero P; Palomero Rodríguez MA; Tormo las de Heras C; Rodríguez Pérez E; Goldman Tarlousky L
    Rev Esp Anestesiol Reanim; 2007 Mar; 54(3):155-61. PubMed ID: 17436653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
    Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topical tranexamic acid in open heart surgery.
    Abul-Azm A; Abdullah KM
    Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
    Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
    Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery.
    Schindler E; Photiadis J; Sinzobahamvya N; Döres A; Asfour B; Hraska V
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):495-9. PubMed ID: 20832330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid therapy in pediatric cardiac surgery: a single-center study.
    Giordano R; Palma G; Poli V; Palumbo S; Russolillo V; Cioffi S; Mucerino M; Mannacio VA; Vosa C
    Ann Thorac Surg; 2012 Oct; 94(4):1302-6. PubMed ID: 22819471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.
    Martin K; Gertler R; Sterner A; MacGuill M; Schreiber C; Hörer J; Vogt M; Tassani P; Wiesner G
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):276-80. PubMed ID: 21425054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.